CSI Market
Sign In | Register

Amneal Pharmaceuticals Inc (AMRX) Annual Balance Sheets

Annual · GAAP · USD millions
Access AMRX quarterly Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Amneal Pharmaceuticals Inc finances operations and invests in assets.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent282.03
Restricted Cash and Cash Equivalents, Current28.84
Cash & Short-term Investments310.00
Accounts receivable895.14
Due from Related Parties, Current RE0.00
Inventories606.30
Other Current Assets0.47
Prepaid Expense And Other Assets Current98.40
Total Current Assets1,911.18
Equipment/Property/Plant Net442.95
Goodwill net595.47
Intangible Assets563.50
Other Assets, Noncurrent165.18
Total Assets3,678.28
Liabilities
Accounts Payable and Accrued Liabilities, Current LI761.32
Estimated Litigation Liability, Current43.26
Long-term Debt, Current Maturities LO6.76
Other Liabilities, Current70.30
Total Current Liabilities881.63
Long-term debt2,565.12
Total Long-term Debt2,565.12
Estimated Litigation Liability, Noncurrent LI71.82
Other liabilities, Noncurrent0.00
Operating Lease Right Of Use Asset54.05
Operating Lease Liability Noncurrent33.23
Operating And Finance Lease Liability Current-
Finance Lease Liability Noncurrent54.93
Total Liabilities3,518.57
Stockholders' Equity
Common Stock Value3.15
Additional Paid In Capital Common Stock571.79
Retained Earnings / Accumulated Deficit-535.01
Other Equity-188.56
Common Stockholder's Equity-148.62
Non-controlling interests & other77.29
Total Stockholder's Equity-71.33
Liabilities & Stockholder's Equity3,678.28
4 historic quarters locked

Sign in to unlock the full Amneal Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Amneal Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 27, 2026
  • Source: amrx-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001723128-26-000011

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License